James Roach
James Roach is an experienced NHS director having held roles in hospitals, clinical commissioning groups and in joint roles with social care. James runs Conclusio Limited, developing innovative solutions in health and care systems in UK and China.
Latest articles
New COVID-19 screening technology could test large groups with rapid response
The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...
Distribution and scaling up a Covid-19 vaccine
The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
Distribution and scaling up a Covid-19 vaccine
The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...
New COVID-19 screening technology could test large groups with rapid response
The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...